Chemical Compound

Filgotinib

CAS Registry Number 1206161-97-8
Filgotinib chemical structure
Primary Record

Filgotinib

In stock
5,004 g
Purity
98.9 %
CAS
1206161-97-8

Compound Identifiers & Properties

CAS
1206161-97-8
PubChem CID
49831257
SMILES
C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5
Canonical SMILES
O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1

Names & Synonyms

  • Filgotinib
  • 1206161-97-8
  • Jyseleca
  • GLPG0634
  • filgotinibum
  • GLPG0634 analogue
  • Tasocitinib
  • Filgotinib-d4
  • Filgotinib [INN]
  • GLPG0634 analog
  • GLPG-0634
  • Filgotinib maleate
  • Filgotinib (GLPG0634)
  • Filgotinib (Standard)
  • Filgotinib [USAN:INN]
  • GLPG0634-analogue
  • Filgotinib hydrochloride
  • Filgotinib(GLPG0634)
  • Filgotinib (USAN/INN)
  • GS-6034 FREE BASE
  • RefChem:921607
  • 3XVL385Q0M
  • FILGOTINIB [USAN]
  • GPLG0634
  • UNII-3XVL385Q0M
  • D0SG7B
  • GLPG 0634
  • Filgotinib(GLPG0634)?
  • FILGOTINIB [WHO-DD]
  • 1206101-20-3
  • MFCD20527867
  • Filgotinib (GLPG-0634)
  • C21H23N5O3S
  • SCHEMBL253559
  • DTXSID80152935
  • Filgotinib pound GLPG0643)
  • GTPL7913
  • orb1307080
  • CHEMBL3301607
  • DTXCID7075426
  • N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
  • AMY3802
  • EX-A741
  • SYN1158
  • BDBM103727
  • GLXC-90126
  • HMS3653P15
  • HMS3673E07
  • AOB87315
  • BCP08496
  • RGD09550
  • 2566AH
  • EBC-13676
  • HY-18300R
  • NSC800100
  • s7605
  • ZINC96174616
  • AKOS025291103
  • G146034
  • 5-Thioxo-pyrrolidine-2-carboxylic acid
  • CCG-268951
  • CS-2284
  • DB14845
  • NSC-800100
  • SB16799
  • G-146034
  • KS-0000063T
  • NCGC00345855-01
  • NCGC00345855-07
  • AK171369
  • AS-16295
  • BC600462
  • BF159062
  • DA-33603
  • DA-33604
  • HY-18300
  • N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
  • B1130
  • FT-0700114
  • FT-0761510
  • SW220020-1
  • N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
  • A14232
  • D10871
  • P12798
  • US8563545, 1
  • EN300-7419864
  • A892158
  • SYN1158;GLPG 0634; GLPG-0634; Filgotinib
  • BRD-K16803204-001-01-6
  • Q19904163
  • Z2037280227
  • G-146034-101
  • N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide.
  • Small molecule, JAK1/JAK2 inhibitor (rheumatoid arthritis), Galapagos/GSK
  • 2041095-50-3
  • CYCLOPROPANECARBOXAMIDE, N-(5-(4-((1,1-DIOXIDO-4-THIOMORPHOLINYL)METHYL)PHENYL)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)-
  • GLPG-0634|||N-[5-[4-[(1,1-Dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
  • N-(5-(4-((1,1-dioxo-1,4-thiazinan-4-yl)methyl)phenyl)-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide
  • N-(5-(4-((1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl)phenyl)-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide
  • N-(5-(4-((1,1-OXO-.LAMBDA.6-THIOMORPHOLIN-4-YL)METHYL)PHENYL((1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE
  • n-(5-(4-((6-cyanopyridin-3-yl)methoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
  • N-(5-{4-[(1,1-Dioxidothiomorpholin-4-Yl)methyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-Yl)cyclopropanecarboxamide
  • N-(5-{4-[(1,1-Dioxo-1lambda~6~-thiomorpholin-4-yl)methyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
  • N-(5-{4-[(1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
  • N-(5-{4-[(6-Cyano-3-pyridinyl)methoxy]phenyl}[1,2,4]triazolo[1,5- a]pyridin-2-yl)cyclopropanecarboxamide
  • N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxa